Taipei, Taiwan

Yoav Keynan

This inventor holds 1 USPTO granted patent. Top assignee: National Taiwan University. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoav Keynan. Retrieved from https://idiyas.com/inventor/yoav-keynan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yoav Keynan: Innovator in Serotype Identification

Introduction

Yoav Keynan is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of molecular biology, particularly in the identification of serotypes through innovative methods.

Latest Patents

Keynan holds a patent related to a method of identifying a serotype, specifically utilizing polymerase chain reaction (PCR) primer sets. This method is designed according to a fragment of a capsular polysaccharide synthesis (cps) region to identify the K57 or NTUH-N1 serotype. The NTUH-N1 serotype is a novel discovery that differs from the previously reported 77 serotypes. His PCR-based cps genotyping method addresses the issues of insufficient specificity and sensitivity found in conventional immune methods. This innovative approach can be applied in clinical diagnosis, offering advantages such as rapidity and low cost. Additionally, it reduces the rate of unidentifiable strains.

Career Highlights

Keynan is affiliated with National Taiwan University, where he continues to advance research in his field. His work has garnered attention for its practical applications in clinical settings.

Collaborations

Keynan has collaborated with notable colleagues, including Jin-Town Wang and Yi-Jiun Pan, contributing to the advancement of research in serotype identification.

Conclusion

Yoav Keynan's innovative methods in serotype identification represent a significant advancement in molecular biology. His contributions are poised to enhance clinical diagnostics and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…